Lynne Shinto
Professor of Neurology, School of Medicine · Oregon Health & Science University
Credentials: · · ·
History
- 2001–2003
- 1996–2000
- 1997–2000
Research
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial
JAMA · 2010 · 560 citations
Journal of Alzheimer s Disease · 2014 · First of 11 authors · Corresponding · 221 citations
A phase I trial of andrographolide in HIV positive patients and normal volunteers
Phytotherapy Research · 2000 · 204 citations
- DB
15 papers
- VY
9 papers · 2 as a fellow

7 papers

7 papers

6 papers
- AH
2 papers
- CM
2 papers · 2 as a resident

2 papers
Grants
- 2013–2020
Omega 3 Pufas for the Vascular Component of Age-Related Cognitive Decline.
National Institute on Aging · R01
Contact PI · $3M · Oregon Health & Science University
- 2010–2015
Lipoic Acid and Omega-3 Fatty Acids in Alzheimer's Disease
National Institute on Aging · R01
Contact PI · $1.5M · Oregon Health & Science University
- 2004–2010
Fish Oil for Depression in Multiple Sclerosis
National Center for Complementary and Integrative Health · K23
Contact PI · $555.3K · Oregon Health & Science University
- 2003–2007
Fish Oil & Alpha Lipoic Acid in Mild Alzheimer's Disease
National Institute on Aging · R21
Contact PI · $359.3K · Oregon Health & Science University
Clinical trials
- 2018–2019
Feru-guard for Behavioral Symptoms in Dementia
Principal investigator · Unknown · Phase 2
Glovia Co., Ltd.
- 2015–2016
Principal investigator · Completed
Oregon Health and Science University
- 2014–2016
Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Principal investigator · Completed · Phase 1, Phase 2
Oregon Health and Science University
- 2014–2021
n-3 PUFA for Vascular Cognitive Aging
Principal investigator · Unknown · Phase 2
Oregon Health and Science University


